AstraZeneca PLC (AZN) Boosts Open Innovation Efforts With New Tactic
3/26/2014 7:51:21 AM
Anglo-Swedish drug major AstraZeneca’s IMED Biotech unit has launched a dedicated web site to support an increasing range of open innovation programs and to better facilitate research collaborations with academia, industry, non-governmental organizations (NGOs) and governments.
Help employers find you! Check out all the jobs and post your resume.
comments powered by